Please participate in our PEDSpace User Satisfaction Survey https://redcap.chop.edu/surveys/?s=79H8MN3YREN9HX37
ConceptSet

Proton-Pump Inhibitor, Drug Exposure


Variable Name

rx_ppi

Refreshed Date

2022-08

Files

1 Download↓
rx_2022_08_ProtonPumpInhibitors_V1.csv (666.81 KB)
↓

Tags

Level of Review

Data Model

Vocabularies


Concept set intended to identify patients with an exposure to a proton-pump inhibitor.


Variable Status

Funder(s)

Provenance

Health Services and Clinical Characteristics that Precede Diagnosis of Primary Hyperoxaluria Type 1 (Alnylam)

Description

This medication concept set identifies exposures to one of the following proton-pump inhibitors: omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole, or dexlansoprazole.

Medication Term Classes

Clinical Subjects Headings

Development Code

Study Variable Applications

Health Services and Clinical Characteristics that Precede Diagnosis of Primary Hyperoxaluria Type 1
Study Dates:2022-01 - 2022-12Sponsor Site:Children's Hospital of Philadelphia
Study to determine the clinical features and health services utilization of individuals with primary hyperoxaluria type 1 (PH1) that precede the diagnosis of PH1. Conclusion of the study resulted in the identification of a set of characteristics that precede diagnosis of PH1 and differentiate children from PH1 children with early onset idiopathic kidney stone disease.

Published Research Applications

Data Source

Related Phenotype

Related Person

Related Concept Set

Related Code

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.